2-Aminoacetophenone CAS:551-93-9

2-Aminoacetophenone

Chemical Name:2-Aminoacetophenone
CAS.NO:551-93-9
Synonyms:2-Aminoacetophenone
2-amino acetophenone
2-Acetylaniline
o-acetylaniline
O-AMINOACETOPHENONE
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 251.8±13.0 °C at 760 mmHg
Melting Point 20 °C
Molecular Formula C8H9NO
Molecular Weight 135.163
Flash Point 106.1±19.8 °C
 
Specification:
Appearance:Colorless to light yellow liquid
Assay:≥98.0%
Melting Point:18-21°C
Others:≤2.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Linagliptin(CAS:668270-12-0).



We are professional 2-Aminoacetophenone manufacturer and O-AMINOACETOPHENONE supplier in China, We offer quality o-acetylaniline you can fully trust, also we have India factory and producer of O-AMINOACETOPHENONE,Pls send inquiry of O-AMINOACETOPHENONE CAS:551-93-9 to info@nbinno.com if you have any interests, thank you!


Related News: China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price.2-Chloroanisole Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.13472-60-1 In these situations, the API is not a single substance but the culmination of various ingredients.4-bromo-3- (trifluorometil) anilina CAS:393-36-2 A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).